As the months ticked by in his job search, Albert started to wonder if there was something wrong with him. He got advice on how to regulate his emotions, and how to be more self-confident.

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as multiple myeloma asset inobrodib progresses to late-stage clinical development.

Despite some notable successes, including U.S. approval in January of a nonopioid painkiller by Boston biotech Vertex, there are few signs the industry — responsible for more than 115,000 ...

Despite some notable successes, including US approval in January of a nonopioid painkiller by Boston biotech Vertex, there are few signs the industry — responsible for more than 115,000 ...

Boston Children’s pauses move into Fenway lab building New Cambridge biotech wants to stop disease before it starts New Cambridge biotech wants to stop disease before it starts Thermo Fisher ...

The Boston biotech is also looking into "strategic options" after its only clinical-stage drug showed disappointing Phase 1 trial results. Ed Kaye, founding CEO of Stoke Therapeutics, steps down ...

Local biotech leaders say the Trump immigration policies may deter foreign scientists from coming to the U.S., hindering the life sciences workforce and drug development. Fruehauf steps aside at ...

“Boston has emerged as a particularly vibrant hub for female biotech founders, with women-led companies securing a sizable share of the region’s early-stage life sciences investments ...